Physician

Peter David Freeman, M.D.

According to 2025 Medicare claims, Peter Freeman, M.D. (NPI: 1467657510) practices ophthalmology in the Reno, NV market, with the plurality of this provider's patient population coming from Washoe, NV. This provider's primary affiliated billing organization is P DAVID FREEMAN MD LTD (NPI: 1154811461; TIN: 824083343) and primary practice location at 89511-1228.

Freeman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 700 traditional Medicare patients, billed 13,039 HCPCS/CPT codes, and received $775,118 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 694 prescription claims across 238 beneficiaries totaling $253,366 in drug costs, led by Xiidra (Lifitegrast). Open Payments data shows 26 records totaling $1,687. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $13,074 to $775,118. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,188 to $253,366. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$388K$775K2018 Medicare payment: $13,074 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $179,095 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $335,650 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $449,668 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $520,700 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $477,389 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $775,118 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201857157$13,074
20192771,464$179,095
20204842,602$335,650
20216013,481$449,668
20226934,370$520,700
20236866,722$477,389
202470013,039$775,118

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$127K$253K2017 Drug cost: $1,188 (USD; Tot_Drug_Cst)2018 Drug cost: $3,226 (USD; Tot_Drug_Cst)2019 Drug cost: $19,521 (USD; Tot_Drug_Cst)2020 Drug cost: $47,263 (USD; Tot_Drug_Cst)2021 Drug cost: $121,011 (USD; Tot_Drug_Cst)2022 Drug cost: $167,956 (USD; Tot_Drug_Cst)2023 Drug cost: $168,283 (USD; Tot_Drug_Cst)2024 Drug cost: $253,366 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171520$1,188
20181629$3,226
201977295$19,521
2020139539$47,263
2021227874$121,011
2022193663$167,956
2023199668$168,283
2024238694$253,366

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more199199$111
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more192228$94
92014Established patient complete exam of visual system317380$81
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more146205$62
92134Imaging of retina5931,074$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XiidraLifitegrast431,828$40,167
RestasisCyclosporine371,350$28,346
TyrvayaVarenicline Tartrate23986$19,632
CyclosporineCyclosporine13750$10,234
MieboPerfluorohexyloctane/Pf14480$9,988

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.26$1,687Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Peter David Freeman, M.D.?

Tedicare shows public-source Medicare data for Peter David Freeman, M.D. (NPI 1467657510), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Peter David Freeman, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Peter David Freeman, M.D.?

Peter David Freeman, M.D. is linked to P DAVID FREEMAN MD LTD (billing NPI 1154811461) in the available physician profile data.

Does Peter David Freeman, M.D. have Open Payments data?

Peter David Freeman, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.